Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients?
Pyne, Nigel J. and Pyne, Susan (2018) Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients? Frontiers in Oncology, 8 (417). pp. 1-3. ISSN 2234-943X (https://doi.org/10.3389/fonc.2018.00417)
Preview |
Text.
Filename: Pyne_Pyne_FiO2018_Does_the_sphingosine_1_phosphate_receptor_1_provide_a_better.pdf
Final Published Version License: Download (101kB)| Preview |
Abstract
Recently, Lei et al., (2018) published an article in Cancer Medicine claiming a survival benefit of sphingosine 1-phosphate (S1P) and sphingosine 1-phosphate receptor 1 (S1P1) expression in breast cancer patients. This controversial study opposes the prevailing view concerning the deleterious role of S1P in cancer. This is discussed in depth in the current opinion article.
-
-
Item type: Article ID code: 65555 Dates: DateEvent27 September 2018Published10 September 2018AcceptedSubjects: Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer) Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 27 Sep 2018 13:18 Last modified: 19 Mar 2024 02:35 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/65555
CORE (COnnecting REpositories)